Vaxil Bio Ltd V.VXL

Alternate Symbol(s): VXLLF

Healthcare Biotechnology

Vaxil Bio Ltd. is a Canada-based biotechnology company. The Company is focused on a drug discovery and development platform based on Signal Peptides (SPs) which the Company deploys to fight infectious diseases and cancer. The Company’s most advanced product, ImMucin, a MUC1 SP-derived vaccine, completed a Phase I/II clinical trial in multiple myeloma. The Company also has a SP-based COVID-19 vaccine candidate and a SP-based tuberculosis vaccine / treatment candidate. In addition, The Company has mAb candidates for the treatment of oncology and infectious diseases to be used alone, and in combination with other treatments. It has also initiated a pre-clinical program for a drug delivery polymer that targets high affinity E-selectin (P-Esbp), which the Company licensed for development and commercialization from BGN Technologies. It exploits the properties of SP domains on crucial proteins to develop targeted therapies against cancer targets and infectious disease pathogens.

TSXV:VXL - Post by User

Vaxil Bio Ltd

Bullboard Posts

Comment by BronxBullon Mar 12, 2020 3:20pm

65 Views

Post# 30800709

RE:Canaccord Selling?

Nope. I'd say go look at who the investment banker on the board is but the site is still down. Day traders. They were buying/selling heavy in the teens as well.

BMW4FUN wrote: How many shares does Canaccord have of VXL? Did they do the financing for the warrants because all they"ve been doing is selling for the last two weeks and no buying.

Staying Long

Bullboard Posts

Global Tungsten Market and Supply Security